药理学-英文版-留学生与双语教学用 PDF下载 娄建石 百度云 电子书 下载 电子书下载
PDF电子书下载不求人，看这篇文章就够了→ http://www.chendianrong.com/pdf#730238483
PDF电子书下载不求人，看这篇文章就够了→ http://www.chendianrong.com/pdf#730238483
<p>书名:药理学-英文版-留学生与双语教学用</p><p>作者:娄建石</p><p>页数:381</p><p>定价:¥79.8</p><p>出版社:清华大学出版社</p><p>出版日期:2015-07-01</p><p>ISBN:9787302384830</p><p><h2>本书特色</h2></p>[<p>

	　　娄建石主编的《药理学（留学生与双语教学用英文版）》系统地介绍了药理学的基本知识，包括常用药物的作用和原理、临床应用、不良反应以及药物相互作用等。内容简明易懂，适合临床医学专业学生初步学习药理学的入门教材，也可作为其他医学相关专业学生学习药理学的教材，如护理学、口腔医学、麻醉学、中西医结合医学、医学检验、医学影像、公共卫生和药学专业等。本书也可供医药卫生专业工作人员学习和应用药理学的参考教材。


	 

                                        </p>]<p><h2>目录</h2></p>
    chapter 1  introduction  i. development of pharmacology  ii. new drug researchchapter 2  pharmacodynamics  i. general classification of drug effects  ii. dose-effect relationship  iii. receptor theory and drug receptor interaction  iv. receptor families and their transducer and effector molecules  v. relationship between regulatory mechanisms of receptors and the pharmacological action  vi. mechanism of actionchapter 3  pharmacokinetics  i. drug transport across membranes  ii. the dynamics of drug absorption, distribution, and elimination  ii. general principles of pharmacokineticschapter 4  pharmacogenetics  i. the objectives of research in pharmacogenetics  ii. the effect of genetic factors on drug reactions  iii. the racial difference of drug reaction and metabolismchapter 5  autonomic pharmacology  i. anatomy and neurotransmitter chemistry of the autonomic nervous system  ii. biosynthesis and metabolism of transmitters  iii. locations of autonomic receptors  iv. presynaptic regulation of transmitter release  v. functional organization of autonomic activity  vi. coupling mechanism of receptor-effect  vii. mode of action of autonomic nervous system drugs  viii. classification of autonomic nervous system drugschapter 6  cholinoceptor-activating and cholinesterase-lnhibiting drugs  i. direct-acting cholinoceptor stimulants  ii. cholinesterase inhibitorschapter 7  organophosphates anticho:inesterase intoxication and cholinesterase reactivators...  i. organophosphates anticholinesterase intoxication  ii. cholinesterase reactivatorchapter 8  m cholinoceptorantagonists  i. natural m cholinoceptor blocking drugs  ii. synthetic spasmolytic drugschapter 9  n cholinoceptorantagonists  i. n1 cholinoceptor blocking drugs  ii. n2 cholinoceptor blocking drugschapter 10  adrenoceptor-activating drugs  i. chemical structure  ii. classification  iii. mixed α and β receptor agonists  iv. α receptor agonists  v. β receptor agonists  vi. dopaminergic receptor agonistschapter 11  adrenoceptor blocking drugs  i. a receptor antagonists  ii. β receptor antagonists  iii. a, β receptor antagonistschapter 12  sedative-hypnotics drugs  i. introduction  ii. benzodiazepines  iii. barbiturates  iv. other sedative-hypnoticschapter 13  antiepileptic drugs  i. classification of seizure types  ii. drugs used in seizures  iii. selectivity and withdrawal of antiepileptic drugs  iv. anticonvulsant drugschapter 14  psychotropic drugs  i. antipsychotic drugs  ii. antimanic drugs  iii. antidepressantschapter 15  antiparkinsonism drugs  i. dopaminergic drugs  ii. anticholinergic drugs  iii. otherschapter 16  antipyretic-analgesic and antiinflammatory drugs  i. introduction  ii. salicylates  iii. anilines  iv. pyrazolones  v. others  vi. analgesic compounds  vii. slow acting antirheumatic drugs  viii. antigout drugschapter 17  narcotic analgesics  i. introduction  ii. opioid receptor agonists  iii. opioid receptor antagonistschapter 18  central stimulants  i. cerebral stimulants  ii. medullary stimulantschapter 19  drugs used in the treatment of heart failure  i. pathophysiology of congestive heart failure  ii. diuretics  lii. aldosterone antagonists  iv. inhibitors of raas: acei and at1 receptor antagonists  v. β adrenergic receptor blocking agents  vi. vasodilators  vii. cardiac glycosides  vs. [3 adrenergic receptor stimulators  ix. phosphodiesterase inhibitorschapter 20  antihypertensive drugs  |. introduction  ii. drugs that alter sodium and water balance  ill. drugs that alter sympathetic nervous system function  iv. vasodilators  v. drugs that interfere with the renin-angiotensin system  vi. clinical pharmacology of antihypertensive drugschapter 21  anti-angina pectoris drugs  i. introduction  ii. nitrates and nitrites  iii. calcium channel blockers  iv. /3 receptor antagonistschapter 22  antiarrhythmic drugs  i. introduction  ii. class i a  iii. class i b  iv. class i c  v. class ii  vi. class iii  vii. class iv  viii. otherschapter 23  autihyperlipidemic drugs  i. atherogenesis  ii. lipoprotein transport  iii. dyslipidaemia  iv. antihyperlipidemic drugschapter 24  diuretic and dehydrant drugs  i. kidney structure and function  ii. diuretics  iii. osmotic diuretics (mannitol, sorbitol, glucose, urea)chapter 25  antiasthmatie drugs  i. bronchodilators  ii. anti-inflammatory drugschapter 26  drugs used in gastrointestinal diseases  i. drugs used to treat peptic ulcer  1i. antiemetic drugs  iii. antidiarrheal drugs  iv. laxatives.chapter 27  drugs affecting uterine motility  i. drugs that stimulate uterine contraction  ii. drugs that inhibit uterine contractionchapter 28  anticoagulants and coagulants  i. introduction  ii. anticoagulants  iii. antiplatelet drugs  iv. fibrinolytic drugs  v. coagulantschapter 29  histamine and antihistamine drugs  i. histamine  ii. h1 receptor antagonists  iii. h2 receptor antagonistschapter 30 adrenocorticosteroids  i. introduction  ii. glucocorticoids  iii. mineralocorticoidschapter 31  drugs affecting the thyroid gland  i . thyroid hormone (th)  ii. antithyroid drugschapter 32  antidiabetic drugs  i. insulin  ii. oral hypoglycemic drugs  iii. current treatment optionschapter 33  introduction to antibacterial drugs  i. specialty terms  h. antimicrobial mechanisms  iii. mechanism of resistance to antibioticschapter 34  syntheticantimicrobial drugs  i. sulfonamides  ii. trimethoprim  iii. quinoloneschapter 35  β-lactam antibiotics  i. penicillins  ii. cephalosporins  iii. other β-lactam drugschapter 36  macrolides, lincosamides and glycopeptides  i. macrolides  ii. lincosamides  iii. glycopeptideschapter 37  broad-spectrum antibiotics  i. tetracyclines  ii. chloramphenicolschapter 38  aminoglycosides and polypeptides  i. aminoglycosides  ii. polypeptideschapter 39  antifungal drugs  i. antibiotics  ii. azole antifungal drugs  11i. allylamine antifungal drugs  iv. pyrimidine antifungal drugschapter 40  antiviral drugs  i. anti-human immunodeficiency virus drugs  ii. anti-herpersvirus drugs  iii. anti-influenza drugs  iv. anti-hepacivirus drugschapter 41  antimycobacterial drugs  i. introduction  ii. first-line drugs used in tuberculosis  iii. alternative second-line drugs in treatment of tuberculosis  iv. combination chemotherapy of tuberculosischapter 42  antimalarial drugs  i. plasmodium life cycles and action of antimalarial drugs  ii. antimalarial drugs mainly applied to control symptoms  iii. antimalarial drugs mainly applied to control relapse and transmission  iv. antimalarial drugs mainly applied to causal prophylaxischapter 43  amebicides  i. life cycles of entamoeba histolytica and action of amebicides  ii. luminal amebicides  iii. extraintestinal amebicides  iv. luminal and simultaneously extraintestinal amebicideschapter 44  anthelmintic drugs  i. nematocides  ii. taeniacides  iii. anti-trematode drugschapter 45  antineoplastic drugs  i. introduction  ii. cytotoxic drugs  iii. non-cytotoxic drugsreferences
